✨ 5 results found - Searched 21219 records in 4ms.
Tesis
Perbandingan kesintasan pasien karsinoma hepatoseluler awitan dini dan awitan lanjut serta faktor-faktor yang memengaruhi
2024 | BY Ibrahim Achmad - Chyntia OM.Jasirwan - WULYO Rajabto - Murdani Abdullah- Comparison of hepatocellular carcinoma survival in early-onset and late-onset patients along with predicting factors.
- Nomor Panggil T24081fk
Tesis
Perbandingan kesintasan satu tahun pasien karsinoma hepatoselular di Rumah Sakit Cipto Mangunkusumo periode 2013-2014 dengan periode 1998-1999
2015 | BY Cosmas Rinaldi Adithya Lesmana - Esthika Dewiasty - Imelda Maria Loho - Irsan Hasan- Hepatocellular carcinoma in Cipto Mangunkusumo Hospital: comparison of one-year survival rate between 2013-2014 and 1998-1999.
- Nomor Panggil T 15 412 FK
Tesis
Kesintasan karsinoma sel hati pascareseksi pada karakteristik pasien di RS Dr. Cipto MAngunkusumo dan faktor-faktor yang memengaruhi
2021 | BY Diah Asih Lestari - Ridho Ardhi Syaiful - Wifanto Saditya Jeo- Post resection survival rate of hepatocellular carcinoma patients in DR Cipto Mangunkusumo National General Hospital and associated factors.
- Nomor Panggil T21470fk
Tesis
Perbandingan antara rasio neutrofil limfosit dan indeks imuninflamasi sistemik sebagai prediktor kesintasan satu tahun pada pasien karsinoma sel hati tahap lanjut yang tidak menjalani terapi
2021 | BY Lutfie - Imelda Maria Loho - Juferdy Kurniawan - Ikhwan Rinaldi - Irsan Hasan - KHIE CHEN- Comparison between neutrophil lymphocyte ratio and systemic immune-inflammation index as predictors of oneyear survival in untreated advanced liver cell carcinoma patients.
- Nomor Panggil T21365fk
Tesis
Efektivitas dan Keamanan Sorafenib Dosis Inisiasi 400 mg Dibandingkan Sorafenib Dosis Inisiasi 800 mg terhadap Kesintasan Pasien Karsinoma Sel Hati Stadium Lanjut dan Intermediet: Suatu Telaah Sistematis dan Meta-analisis
2021 | BY Roland Helmizar - Juferdy Kurniawan - Alvina Widhani - Rudi Putranto- Effectiveness and Safety of Sorafenib 400 mg Initial Dose Compared with Sorafenib 800 mg Initial Dose on Survival in Patients with Advanced and Intermediate Stage Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
- Nomor Panggil T21339fk